Sage therapeutics stock price history

3 Oct 2019 Stocks quotes in this article: SAGE. During the In this daily bar chart of SAGE, below, we can see a downtrend from July. Prices have fallen  12 Mar 2020 SAGE Therapeutics Inc (SAGE) is near the bottom in its industry group of -$ 7.40, or -17.49% from the previous closing price of $42.30.

Sage Therapeutics - SAGE stock price history, 1 day charts ... Sage Therapeutics price history, SAGE 1 day chart with daily, weekly, monthly prices and market capitalizations SAGE Stock Rating and Data | Sage Therapeutics - GuruFocus.com SAGE stock rating and analysis - Sage Therapeutics : a summary of key financial strength and profitability metrics. Home Homepage Membership Levels Membership Data Coverage Complete Stock List Founder's Message The book Value Investing Forum Podcast Free Trial

Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, today announced that on April 1, 2020, the Compensation Committee of Sage’s Board of Directors granted non-qualified stock options to purchase

Sage Therapeutics Stock Quote. SAGE - Stock Price, News ... Sage Therapeutics stock quote and SAGE charts. Latest stock price today and the US's most active stock market forums. Sage Therapeutics (SAGE) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more. Your Recent History NASDAQ. SAGE SAGE - Sage Therapeutic Com Stock Price - Barchart.com Why Sage Therapeutics (SAGE) Stock Might be a Great Pick Zacks Equity Research - Zacks Investment Research - Thu Mar 12, 7:45AM CDT Zacks Equity Research - ZACKS - Thu Mar 12, 7:45AM CDT Sage Therapeutics (SAGE) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well. Sage Therapeutics, Inc. (SAGE) stock price, quote, history ... Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, today announced next steps in the Landscape Program, the clinical program evaluating zuranolone (SAGE-217) for the treatment of postpartum Sage Therapeutics Price | Markets Insider

29 Mar 2020 Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock's existing status and the future 

On average, they expect SAGE Therapeutics' stock price to reach $100.05 in the next twelve months. This suggests a possible upside of 285.1% from the stock's current price. View analysts' price targets for SAGE Therapeutics . SAGE Stock Quote - SAGE Therapeutics, Inc. Stock Price Today

Sage Therapeutics Stock Is a Steal, Analyst Says - Barron's

Learn more about Sage Therapeutics, a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. Sage Therapeutics Inc. Historical Quotes - MarketWatch

Sage Therapeutics has 675 employees across 3 locations and $6.87 M in annual Sage Therapeutics stock rises after FDA approves first postpartum depression drug Share Price (Apr 2020), $26.8 Sage Therapeutics Market Cap History.

SAGE Stock Price and Chart — NASDAQ:SAGE — TradingView Sage Therapeutics (NASDAQ:SAGE) announces next steps in the Landscape Program, the clinical program evaluating zuranolone (SAGE-217) for the treatment of postpartum depression (PPD) and major depressive disorder (MDD), following a Breakthrough Therapy guidance meeting with the FDA.

Find the latest historical data for Sage Therapeutics, Inc. Common Stock (SAGE) at Nasdaq.com. Sage Therapeutics, Inc. (SAGE) Stock Price, Quote, History ... Find the latest Sage Therapeutics, Inc. (SAGE) stock quote, history, news and other vital information to help you with your stock trading and investing. SAGE Stock Price, Forecast & News (SAGE Therapeutics)